$SMTK

SmartKem, Inc. (SMTK): Entry into a Material Definitive Agreement

SmartKem, Inc. (SMTK) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-4.1 2 tm2621383d1_ex4-1.htm EXHIBIT 4.1 Exhibit 4.1 FERROX CRITICAL MINERALS CONVERTIBLE PROMISSORY NOTE Original Issuance Date: July 27, 2026 FOR VALUE RECEIVED, Ferrox Critical Minerals , a a British Virgin Islands (“ BVI ”) company (the “ Company ”), promises to pay to the

Original reporting
Published Jul 27, 2026, 8:05 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 27, 2026, 8:06 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$SMTK
Neutral
medium confidence
Mentioned
$SMTK
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$SMTKNeutralMed
01

Why it matters

The disclosed note terms introduce financing and conversion/dilution risk into SMTK’s capital structure, with a defined maturity (Jan 31, 2027) and higher economics upon default (15% interest plus daily default management fees).

02

Market read

Convertible note disclosures are typically repriced quickly as traders model dilution and credit risk; this filing provides concrete terms (principal, interest, maturity, conversion price framework).

03

What to watch

Traders should check the full 8-K for the noteholder identity, any conversion triggers, covenants, and whether the company simultaneously announced operational milestones that reduce default risk.

Relevance 6/10Novelty 6/10Timing: after-hours filing of an 8-K convertible note terms disclosure

Background

The 8-K reports entry into a material definitive agreement and unregistered sales of equity securities, including a convertible promissory note.

Company-level read

Ticker impact

$SMTKNeutralMedium confidence
Context

SmartKem entered a material definitive agreement via a $4.9M convertible promissory note with 5% interest and a Jan 31, 2027 maturity.

Expected impact

Near-term volatility possible as traders price the conversion mechanics and potential dilution risk; direction depends on perceived need for capital and conversion likelihood.

Evidence & confidence

This is a fresh 8-K disclosure of a convertible note (principal, interest, maturity, conversion price framework). The excerpt does not include the noteholder identity, conversion discount specifics beyond the $80M equity value cap, or whether the company has other financing, limiting precision on dilution impact.

Market effects

Convertible financings can signal funding needs in small-cap biotech/tech-adjacent issuers, but no sector-wide read-across is provided here.

No clear regional spillover beyond US small-cap credit/equity sentiment.

The note involves a BVI entity lender, but the disclosure does not indicate broader cross-border market effects.

Counterpoint

If the company can convert on favorable terms or the note is non-dilutive in practice (low conversion likelihood), the market may over-discount dilution risk.

Key entities

  • SmartKem, Inc.

    Subject of the 8-K, issuing the convertible promissory note and related unregistered equity securities.

  • Ferrox Critical Minerals

    BVI company providing the $4.9M convertible promissory note financing.

Related articles

$SRXHMedAI 8/10

SRx Health Solutions Acquires 4.99% of Smartkem, Inc. (NASDAQ: SMTK)

SRx Health Solutions (NYSE American: SRXH) said it acquired 4.99% of Smartkem (NASDAQ: SMTK) via a shelf take down, and also bought convertible preferred securities in a non-brokered private placement, according to the company. SRx noted it filed an SEC Form S-4 to register shares for the proposed transaction involving EMJ Crypto Technologies (EMJX).